Decreased serum PON1 arylesterase activity in familial hypercholesterolemia patients with a mutated LDLR gene

Decreased serum PON1 arylesterase activity in familial hypercholesterolemia patients with a mutated LDLR gene

Abstract Paraoxonase 1 (PON1) is a serum enzyme associated with high density lipoprotein (HDL) regulation through its paraoxonase and arylesterase activity. PON1 inhibits the oxidation of HDL and low density lipoprotein (LDL), and is involved in the pathogenesis of a variety of diseases including at...

Full description

Bibliographic Details
Main Authors:	Muhammad Idrees, Abdul Rauf Siddiq, Muhammad Ajmal, Muhammad Akram, Rana Rehan Khalid, Alamdar Hussain, Raheel Qamar, Habib Bokhari
Format:	Article
Language:	English
Published:	Sociedade Brasileira de Genética 2018-07-01
Series:	Genetics and Molecular Biology
Subjects:	Paraoxonase-1 hypercholesteremia arylesterase LDLR mutation
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1415-47572018000400570&lng=en&tlng=en

Similar Items

Evaluation of paraoxonase, arylesterase, and homocysteine thiolactonase activities in patients with diabetes and incipient diabetes nephropathy
by: Ayan Durmu§, et al.
Published: (2019-01-01)

Serum arylesterase and paraoxonase activities in patients with ovarian tumors
by: Slawomir Michalak, et al.
Published: (2014-12-01)

Total oxidative stress, paraoxonase and arylesterase levels at patients with pseudoexfoliation syndrome and pseudoexfoliative glaucoma
by: Feyza Dursun, et al.
Published: (2015-10-01)

Total oxidant status, total antioxidant status, and paraoxonase and arylesterase activities during laparoscopic cholecystectomy
by: Hande Koksal, et al.
Published: (2010-01-01)

Arylesterase Phenotype-Specific Positive Association Between Arylesterase Activity and Cholinesterase Specific Activity in Human Serum
by: Yutaka Aoki, et al.
Published: (2014-01-01)

Serum Lipid Profiles, Relationship Between Paraoxonase/Arylesterase Activity and High-density Lipoprotein Levels in Patients with Migraine
by: Yasemin Eren, et al.
Published: (2017-09-01)

Evaluation of serum paraoxonase and arylesterase activities in ankylosing spondylitis patients
by: Fazile Hatipoglu Erdem, et al.
Published: (2010-01-01)

Paraoxonase and Arylesterase activities of human serum paraoxonase in coronary artery disease
by: Abdolkarim Mahrooz, et al.
Published: (2008-11-01)

Arylesterase Activity of HDL Associated Paraoxonase as a Potential Prognostic Marker in Patients With Sepsis and Septic Shock—A Prospective Pilot Study
by: Alexander C. Reisinger, et al.
Published: (2020-10-01)

Arylesterase Activity of Paraoxonase-1 in Serum and Cerebrospinal Fluid of Patients with Alzheimer’s Disease and Vascular Dementia
by: Arianna Romani, et al.
Published: (2020-05-01)

Lipid associated antioxidants: arylesterase and paraoxonase-1 in benign prostatic hyperplasia treatment-naïve patients
by: George Awuku Asare, et al.
Published: (2018-03-01)

Arylesterase activity of Paraoxonase 1 - prognostic factor for one-year survival in patients with acute myocardial infarction
by: Ciumărnean Lorena, et al.
Published: (2018-07-01)

Association between inflammatory markers and serum paraoxonase and arylesterase activities in the general population: a cross-sectional study
by: Christa Meisinger, et al.
Published: (2021-07-01)

Comparison of Total Oxidative Stress, Total Antioxidant Capacity, and Paraoxonase, Arylesterase, and Lipid Peroxidase Levels in Aqueous Humor and Serum of Diabetic and Non-Diabetic Patients with Catarac
by: Cengiz Caner, et al.
Published: (2012-01-01)

Compensatory Paraoxonase and Arylesterase Levels in Hyperbaric Oxygen Treatment of Sudden Sensorineural Hearing Loss
by: Eren Esin, et al.
Published: (2020-03-01)

Endothelial Lipase Modulates Paraoxonase 1 Content and Arylesterase Activity of HDL
by: Irene Schilcher, et al.
Published: (2021-01-01)

Paraoxonase 1 Phenotype and Paraoxonase Activity in Asthmatic Patients
by: Nurhan Sarioglu, et al.
Published: (2015-02-01)

The phenotype distribution of paraoxonase-1 in patients with multiple myeloma, bladder, and colorectal cancer
by: Ellidag Hamit Yasar, et al.
Published: (2014-01-01)

Decreased arylesterase activity and increased total Decreased arylesterase activity and increased total oxidative status in rosacea
by: Sertac Sener, et al.
Published: (2017-10-01)

Therapeutic targets of hypercholesterolemia: HMGCR and LDLR
by: Ma S, et al.
Published: (2019-08-01)

Oxidant/Antioxidant Status, PON1 and ARES Activities, Trace Element Levels, and Histological Alterations in Sheep with Cystic Echinococcosis
by: Kıvanç IRAK, et al.
Published: (2018-09-01)

Correlation between Cholinesterase and Paraoxonase 1 Activities: Case Series of Pesticide Poisoning Subjects
by: S Austin Richard, et al.
Published: (2013-08-01)

Paraoxonase 1 and Non-Alcoholic Fatty Liver Disease: A Meta-Analysis
by: Kazuhiko Kotani, et al.
Published: (2021-04-01)

Calotropis procera (leaves) supplementation exerts curative effects on promoting functional recovery in a mouse model of peripheral nerve injury
by: Shamaila Zafar, et al.
Published: (2021-09-01)

The number of PON1 mutant alleles, but not PON1 phenotype, is associated with Gensini score of coronary damage
by: Ilea Irina, et al.
Published: (2013-12-01)

Paraoxonase (PON1) 55 Polymorphism and Association with Systemic Lupus Erythematosus
by: Fariborz Bahrehmand, et al.
Published: (2013-09-01)

Low Serum Paraoxonase-1 Lactonase and Arylesterase Activities in Obese Children and Adolescents
by: Sandor Raluca, et al.
Published: (2015-12-01)

The change of ghrelin levels in intestinal parasitic infections
by: Erensoy Ahmet, et al.
Published: (2010-01-01)

Study of Oxidative Stress Marker Serum Paraoxonase in Metabolic Syndrome
by: Mohit Rojekar, et al.
Published: (2016-09-01)

Antioxidant Status and Serum Prolidase Activity in Women with Subclinical Hypothroidism
by: Mehmet Ali Eren, et al.
Published: (2015-06-01)

The relationship between serum ferritin levels and serum lipids and HDL function with respect to age and gender
by: Hamit Yasar Ellidag, et al.
Published: (2016-12-01)

Relationship of Serum Paraoxonase Enzyme Activity and Thermal Burn Injury
by: Serap Yildirim, et al.
Published: (2012-12-01)

Evaluation of Serum malondialdehyde concentrations and enzymatic activity of paraoxonase and arile esterase in women with a recurrent spontaneous abortion
by: Sanjadi M, et al.
Published: (2019-12-01)

Determination of serum paraoxonase phenotype distribution by double-substrate method in patients with coronary artery disease
by: Durdi Qujeq, et al.
Published: (2011-04-01)

Endoplasmic reticulum quality control of LDLR variants associated with familial hypercholesterolemia
by: Praseetha Kizhakkedath, et al.
Published: (2019-11-01)

Comparison of the effects of high-dose atorvastatin and high-dose rosuvastatin on oxidative stress in patients with acute myocardial infarction: A pilot study
by: Celal Kilit, et al.
Published: (2017-04-01)

Oxidative stress in the adult and pediatric patients with Crimean-Congo haemorrhagic fever
by: Huseyin Aydin, et al.
Published: (2013-12-01)

Can Visfatin be Considered as a Diagnostic Marker for Diabetic Nephropathy?
by: Hakan Korkmaz, et al.
Published: (2016-03-01)

The Structure and Function of Paraoxonase-1 and Its Comparison to Paraoxonase-2 and -3
by: Ajda Taler-Verčič, et al.
Published: (2020-12-01)

Phenotypical features of heterozygous familial hypercholesterolemia in individuals with LDLR or APOB gene mutations
by: A. N. Meshkov, et al.
Published: (1970-01-01)